- Community-Beiträge
- Aktuellste Threads
| Geld/Brief | 2,30 € / 2,34 € |
| Spread | +1,74% |
| Schluss Vortag | 2,24 € |
| Gehandelte Stücke | 0 |
| Tagesvolumen Vortag | - |
| Tagestief 2,30 € Tageshoch 2,30 € | |
| 52W-Tief 1,12 € 52W-Hoch 5,80 € | |
| Jahrestief 1,61 € Jahreshoch 3,50 € | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -41,85 $ |
| Jahresüberschuss in Mio. | -47,05 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -0,75 $ |
| Gewinnrendite | +45,65% |
| Umsatzrendite | - |
| Return on Investment | -268,92% |
| Marktkapitalisierung in Mio. | 80,93 $ |
| KGV (Kurs/Gewinn) | -1,72 |
| KBV (Kurs/Buchwert) | - |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | - |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Düsseldorf | 2,28 € | +1,79% | 2,24 € | 08:13 | |
| Frankfurt | 2,30 € | +2,68% | 2,24 € | 08:03 | |
| München | 2,24 € | +8,74% | 2,06 € | 12.06.26 | |
| Stuttgart | 2,30 € | +0,88% | 2,28 € | 11:31 | |
| L&S RT | 2,32 € | -0,43% | 2,33 € | 11:51 | |
| NYSE | 2,685 $ | +3,47% | 2,595 $ | 12.06.26 | |
| Nasdaq | 2,68 $ | 0 % | 2,68 $ | 12.06.26 | |
| AMEX | 2,68 $ | - | - | 12.06.26 | |
| Tradegate | 2,20 € | -5,17% | 2,32 € | 11.06.26 | |
| Quotrix | 2,32 € | +2,65% | 2,26 € | 07:27 | |
| Gettex | 2,26 € | +1,80% | 2,22 € | 12.06.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 12.06.26 | 2,24 | 0 |
| 11.06.26 | 2,04 | 0 |
| 10.06.26 | 2,06 | 0 |
| 09.06.26 | 1,97 | 0 |
| 08.06.26 | 1,93 | 0 |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 1,85 € | +21,08% |
| 1 Monat | 1,84 € | +21,74% |
| 6 Monate | 5,20 € | -56,92% |
| 1 Jahr | 1,13 € | +98,23% |
| 5 Jahre | 3,10 € | -27,74% |
| Marktkapitalisierung | 140,15 Mio. € |
| Aktienanzahl | 63,29 Mio. |
| Streubesitz | 49,75% |
| Währung | EUR |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +3,48% | Vanguard Group Inc |
| +1,85% | Marshall Wace Asset Management Ltd |
| +1,66% | Advisor Group Holdings, Inc. |
| +1,21% | Millennium Management LLC |
| +1,21% | BlackRock Inc |
| +0,93% | Geode Capital Management, LLC |
| +0,91% | Sontag Advisory LLC |
| +0,84% | Susquehanna International Group, LLP |
| +0,71% | Two Sigma Investments LLC |
| +0,51% | Commonwealth Equity Services Inc |
| +0,49% | LPL Financial Corp |
| +0,39% | Vivaldi Capital Management, LLC |
| +0,39% | State Street Corp |
| +0,37% | Geneos Wealth Management Inc |
| +0,34% | Sovran Advisors, LLC |
| +0,30% | Jane Street Group LLC |
| +0,28% | RETIREMENT GUYS FORMULA LLC |
| +0,28% | The Goldman Sachs Group Inc |
| +0,27% | UBS Group AG |
| +0,25% | 683 Capital Management LLC |
| +33,56% | Weitere |
| +49,75% | Streubesitz |
MK 103 Mio. $; bei 36 Mio. $ Cash und einem Cashburn von ~8 Mio. $ pro Quartal. Da zuckt bei mir noch nicht mal der kleine Finger.
"The Company believes it has sufficient cash to fund currently planned operations and research and development activities through at least March 31, 2023."
https://investor.galectintherapeutics.com/news-releases/news-release-details/galectin-therapeutics-reports-financial-results-quarter-ended-3
